Durvalumab Plus Concurrent Radiotherapy for Locally Advanced NSCLC
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Durvalumab Plus Concurrent Radiotherapy for Treatment of Locally Advanced Non-Small Cell Lung Cancer: The DOLPHIN Phase 2 Nonrandomized Controlled Trial
JAMA Oncol 2023 Sep 07;[EPub Ahead of Print], M Tachihara, K Tsujino, T Ishihara, H Hayashi, Y Sato, T Kurata, S Sugawara, Y Shiraishi, S Teraoka, K Azuma, H Daga, M Yamaguchi, T Kodaira, M Satouchi, M Shimokawa, N Yamamoto, K NakagawaFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.